Introduction Breast Cancer Awareness Month, observed every October, is an opportunity to emphasize the critical importance of early detection, education, and ongoing advancements in the treatment of breast cancer. With breast cancer being the most common cancer among women worldwide, awareness...

February, marked globally as Cancer Prevention Month, is a time to renew our commitment to reducing the impact of cancer. This month serves as a reminder of the significant strides made in cancer research, treatment, and prevention. However, it also underscores the need for continued vigilance and...

New technology is impacting preventive care and advancing home health care in countless ways, offering more convenience, efficiency, and cost savings. Technology is revolutionizing preventative care, transforming how health care providers diagnose, treat, and monitor patient health. Home health...

Cancer can present itself in many ways and has varying and debilitating symptoms. However, some forms of cancer are chronic and could pose more challenges regarding health care management. Cancer is a serious condition with various causes, and different types of cancer affect people differently....

Sleep deprivation is something that millions of people struggle with in the US. Numerous health complications can develop due to sleep loss. It’s essential to understand the cause to help prevent it and know when it’s time to seek treatment. Many people of all ages experience sleep...

Are you looking to learn more about drug pricing but don’t know where to start? Here’s a comprehensive guide that will provide clarity on this crucial issue. Drug prices in the United States are among the highest in the world, 3.44 times more expensive than the median price in other...

Prescription drug prices are rising more exorbitantly than the rate of inflation. Here are the culprits behind the rising costs of prescription medication. The price of prescription meds in the U.S. has risen dramatically over the past couple of years. This has little to do with inflation rates,...

Inflation directly affects the prices of prescription drugs in the U.S., but the Inflation Reduction Act can help combat the soaring prices and make them accessible to patients. According to a 2022 survey , one in three adults says they haven’t taken prescription medications due to the...

Prescription drug prices are on the rise, and patients will be forced to pay higher prices for the medications they need. Find out how you can navigate – and potentially avoid – cost inflation. Over the past several years, there has been a dramatic uptick in spending on prescription...

Among all developed nations, Americans pay the highest prices for prescription drugs. Here are the main reasons prescription drugs are so expensive in America. The cost of prescription medication in the U.S. has been on the rise for years. Between 2019 and 2020 , the price of most prescription...

Learn to ease the pressure of prescription prices with our list of saving strategies. Key Takeaways: Drug manufacturers in the U.S. set the price of prescription drugs Manufacturers of new drugs must recoup costs to make profit before generic alternatives flood the market This need for profit...

Key Takeaways Most Americans support Medicare price reductions for prescription drugs Many Americans believe the government should be involved in setting price limits for prescription drugs Drug manufacturers and Big Pharma lobbyist groups have argued that lowering the prices of prescription...

Key takeaways: High blood pressure and cancer claim millions of lives every year Chances of developing potentially fatal disease can be significantly reduced through a healthy diet Fruits and vegetables offer multiple benefits Fatty fish is the best meat for preventative care Some of the...

An apple a day isn’t quite enough to keep the doctor away. Read our guide to what real preventative care requires. Key Takeaways: Prioritizing preventative steps delivers multiple benefits. Increased personal awareness, better budgeting, and easier condition management become...

We can’t avoid aging, but we can avoid many risks associated with getting older so we can live longer lives. Here is how physical exercise can help us age healthy. We all age. Staying on top of the right habits will help you avoid many of the serious health issues that come with getting...

Generic medications are just as effective as their brand name counterparts, and they cost 80% to 85% less. Learn more about the differences. One of your first considerations when you’re buying a prescription is likely how much it’s going to cost. You can save money by going with a...

Preventing expensive chronic diseases like diabetes, cancer, and high blood pressure significantly lowers healthcare costs for the industry and for patients. Chronic diseases continue to be one of the largest healthcare issues in the U.S., leading to negative outcomes from disability to death....

  Few prescriptions can be called cheap, but some drug expenses are stratospheric. Here are the nation’s most expensive drugs. Here’s a fact that’s hard to swallow: U.S. prescription drug prices are more than twice as expensive as those in other developed countries,...

Chronic diseases such as cancer, heart disease, and diabetes are among the leading causes of death in the U.S. Here are a few ways you can prevent them now. Avoiding chronic illness can help you lead a longer, healthier life. According to data from the Centers for Disease Control and Prevention...

Struggling with Prescription Costs? Here's How to Save in 2024 Each year, the price of medications continues to rise, with more than 600 drug prices increasing by an average of 5% to 6% back in 2022. As Americans still face financial challenges, partly due to the long-term effects of the COVID-19...

Many Americans are still struggling to cover health care costs as we begin 2022. Hundreds of drugs have already seen price hikes. Learn more about the state of prescription prices during the pandemic. As we begin 2022, many Americans wonder if the cost of their prescriptions will skyrocket in...

Streamlining the process of bringing biosimilars to market is one of the keys to facilitating innovation and reducing healthcare costs, according to US Food and Drug Administration (FDA) Commissioner Scott Gottlieb. Speaking at the Brookings Institution on the release of the FDA’s...

Fulphila (pegfilgrastim-jmdb) is the first biosimilar to Neulasta (pegfilgrastim) to gain approval from the US Food and Drug Administration (FDA). The Mylan GmbH medicine was approved as a treatment to reduce the risk of infection as suggested by febrile neutropenia (fever caused by a lack of...

Lynparza (olaparib tablets) is the first poly (ADP-ribose) polymerase (PARP) inhibitor indicated for the treatment of patients with breast cancer whose tumors have a specific inherited genetic mutation. Lynparza is already approved in the United States as a treatment for a number of other cancers,...

More than four in ten (42 percent) of cancer cases in the United States are linked to risk factors associated with cancer, such as smoking, obesity, poor diet, ultraviolet radiation and physical inactivity, according to a new study conducted by the American Cancer Society. The results of the...

Overweight or obese Americans are at a higher risk of developing cancer, according to the latest Vital Signs report from the Centers for Disease Control and Prevention (CDC). At least 13 different types of cancer are associated with obesity, yet figures suggest more than half of Americans are...

Patients with HER2 breast cancer will have a new treatment option available later this year, following the US Food and Drug Administration's (FDA) approval of the first extended adjuvant treatment for the condition. Nerlynx (neratinib), a kinase inhibitor from Puma Biotechnology, was granted FDA...

A Phase III OlympiAD trial of Lynparza (olaparib) tablets for treating patients with HER2-negative gBRCA-mutated metastatic breast cancer has yielded positive results with a "statistically-significant and clinically-meaningful improvement in progression-free survival". Pharmaceutical firm...